[#item_full_content] Food and Drug Administration (FDA) officials are laying out the agency’s “new framework” for psychedelic medicines, including steps that are taking to “make psychedelic therapies available to patients more quickly, as warranted by the nation’s mental health crisis.” “The ongoing mental health crisis in the United States continues to worsen,” four FDA staffers wrote in
Read More